Literature DB >> 10208289

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt.

A Westrin1, R Ekman, L Träskman-Bendz.   

Abstract

In order to receive a further understanding of stress-regulation in depressed suicide attempters, peptides that are supposed to be related to the stress system (the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system) were studied in plasma. When compared with healthy controls, cortisol was high (p<0.001) and corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) appeared to be low (p<0.001) in patients who had recently attempted suicide. Patients who had repeatedly attempted suicide had the lowest NPY. A correlation between NPY and cortisol (p<0.05) was found in suicidal patients with depression NOS, whereas beta-endorphins correlated with cortisol (p<0.01) in suicidal patients with major depressive disorder. A postdexamethasone decrease of NPY was noted in the controls but not in the patients. These results suggest stress system alterations in suicidal patients with mood disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208289     DOI: 10.1016/s0924-977x(98)00026-1

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  15 in total

1.  Association between a functional polymorphism in the renin-angiotensin system and completed suicide.

Authors:  A Hishimoto; O Shirakawa; N Nishiguchi; T Hashimoto; M Yanagi; H Nushida; Y Ueno; K Maeda
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

2.  Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes.

Authors:  Ke Xu; Kwangik Adam Hong; Zhifeng Zhou; Richard L Hauger; David Goldman; Rajita Sinha
Journal:  Psychoneuroendocrinology       Date:  2011-09-13       Impact factor: 4.905

Review 3.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

4.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 5.  Possible risk factors for increased suicide following bariatric surgery.

Authors:  James E Mitchell; Ross Crosby; Martina de Zwaan; Scott Engel; James Roerig; Kristine Steffen; Kathryn H Gordon; Trisha Karr; Jason Lavender; Steve Wonderlich
Journal:  Obesity (Silver Spring)       Date:  2013-04       Impact factor: 5.002

Review 6.  Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.

Authors:  Konstantinos A Paschos; Stavroula Veletza; Ekaterini Chatzaki
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

7.  Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways.

Authors:  C Anthony Altar; Pascal Laeng; Linda W Jurata; Jeffrey A Brockman; Andrew Lemire; Jeffrey Bullard; Yury V Bukhman; Theresa A Young; Vinod Charles; Michael G Palfreyman
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

8.  Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Authors:  Nicole M Enman; Esther L Sabban; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015-01-01

Review 9.  Role of adult hippocampal neurogenesis in stress resilience.

Authors:  Brunno R Levone; John F Cryan; Olivia F O'Leary
Journal:  Neurobiol Stress       Date:  2014-11-21

Review 10.  The role of neuropeptides in suicidal behavior: a systematic review.

Authors:  Gianluca Serafini; Maurizio Pompili; Daniel Lindqvist; Yogesh Dwivedi; Paolo Girardi
Journal:  Biomed Res Int       Date:  2013-08-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.